Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 20/20 | 0.80 |
| ▸ | ERBB2 | P04626 | 10/20 | 0.78 |
| ▸ | ERBB4 | Q15303 | 3/20 | 0.77 |
| ▸ | FYN | P06241 | 1/20 | 0.77 |
| ▸ | SRC | P12931 | 1/20 | 0.77 |
| ▸ | BLK | P51451 | 1/20 | 0.77 |
| ▸ | BMX | P51813 | 1/20 | 0.77 |
| ▸ | JAK3 | P52333 | 1/20 | 0.77 |
| ▸ | BTK | Q06187 | 1/20 | 0.77 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15782171 | 0.91 | EGFR (0.75) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL2986126 | 0.89 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL12012727 | 0.88 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL2988658 | 0.88 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL2988661 | 0.88 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL2680536 | 0.87 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL29359583 | 0.87 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL7213752 | 0.86 | EGFR (0.89) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL7212665 | 0.86 | EGFR (0.89) | EGFRERBB2ERBB4FYNSRC | |
| SCHEMBL1417861 | 0.85 | EGFR (1.00) | EGFRERBB2ERBB4FYNSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0980244-B1 | USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE | WYETH CORP (US) | 2003-06-04 | — | — | EP | claimed |
| US-6323209-B1 | QUINAZOLINE COMPOUNDS IN THE TREATMENT AND INHIBITION OF COLONIC POLYPS. | AMERICAN CYANAMID COMPANY | 2001-11-27 | — | — | US | claimed |
| EP-1039910-A1 | USE OF QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR TREATING COLONIC POLYPS | American Cyanamid Company (US) | 2000-10-04 | — | — | EP | claimed |
| EP-0980244-A1 | USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE | American Cyanamid Company (US) | 2000-02-23 | — | — | EP | claimed |
| US-5929080-A | ADMINISTERING PHENYLAMINOQUINAZOLINE DERIVATIVE | AMERICAN CYANAMID COMPANY (US) | 1999-07-27 | — | — | US | claimed |
| WO-1999024037-A1 | USE OF QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR TREATING COLONIC POLYPS | AMERICAN CYANAMID COMPANY (US) | 1999-05-20 | — | — | WO | claimed |
| WO-1998050038-A1 | USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE | AMERICAN CYANAMID COMPANY (US) | 1998-11-12 | — | — | WO | claimed |
| US-5760041-A | 4-aminoquinazoline EGFR Inhibitors | AMERICAN CYANAMID COMPANY (US) | 1998-06-02 | — | — | US | claimed |
| EP-0787722-A1 | Substituted quinazoline derivatives | American Cyanamid Company (US) | 1997-08-06 | — | — | EP | claimed |
| US-8765946-B2 | Methods of preparing and using quinazoline and quinoline derivatives | TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) | 2014-07-01 | — | — | US | disclosed |
| US-8765946-B2 | Methods of preparing and using quinazoline and quinoline derivatives | TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) | 2014-07-01 | — | — | US | disclosed |
| US-8765946-B2 | Methods of preparing and using quinazoline and quinoline derivatives | TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) | 2014-07-01 | — | — | US | disclosed |
| EP-2045245-B1 | INREVERSIBLE PROTEIN TYROSINE KINASES INHIBITORS AND THE PREPARATION METHODS AND USES THEREOF | TIAN JIN HEMAY BIO TECH CO LTD (CN) | 2013-10-23 | — | — | EP | disclosed |
| EP-2045245-B1 | INREVERSIBLE PROTEIN TYROSINE KINASES INHIBITORS AND THE PREPARATION METHODS AND USES THEREOF | TIAN JIN HEMAY BIO TECH CO LTD (CN) | 2013-10-23 | — | — | EP | disclosed |
| EP-0980244-A1 | USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE | American Cyanamid Company (US) | 2000-02-23 | — | — | EP | disclosed |
| US-5929080-A | ADMINISTERING PHENYLAMINOQUINAZOLINE DERIVATIVE | AMERICAN CYANAMID COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1999024037-A1 | USE OF QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR TREATING COLONIC POLYPS | AMERICAN CYANAMID COMPANY (US) | 1999-05-20 | — | — | WO | disclosed |
| WO-1998050038-A1 | USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE | AMERICAN CYANAMID COMPANY (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5760041-A | 4-aminoquinazoline EGFR Inhibitors | AMERICAN CYANAMID COMPANY (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0787722-A1 | Substituted quinazoline derivatives | American Cyanamid Company (US) | 1997-08-06 | — | — | EP | disclosed |